Effectiveness of Nivolumab in second-line and later in patients with advanced non-small cell lung cancer in real-life practice in France and Germany: analysis of the ESME-AMLC and CRISP cohorts - Chouaid, Christos; Thomas, Michael; Debieuvre, Didier; Durand-Zaleski, Isabelle; Zacharias, Stefan; Bosquet, Lise; Groth, Annika; Fleitz, Annette; Calleja, Alan; Patel, Sonya; Lacoin, Laure; Daumont, Melinda J.; et al. (Cancers, 2022)
Gesehen am 31.01.2023